Pulmonary embolisms in patients with COVID-19: A prevalence study in a tertiary hospital

Chamorro, E. Martínez; Ostolaza, T. Y. Revilla; Núñez, M. Pérez; Nacenta, S. Borruel; Rodríguez-Guerra, C. Cruz-Conde; Sanz, Yolanda

doi:10.1016/j.rxeng.2020.09.011

Cited by 12 publications

(12 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our result remains, however, lower than that of certain authors of the literature, in particular, Western literature. Indeed, and Ventura-Díaz found a higher prevalence than ours, of 26% and 33%, respectively [ 9 10 ]. The male predominance was also found by Grillet [ 11 ] and Parrek [ 12 ] in, respectively, 70% and 52.6% of cases.…”

Section: Discussionmentioning

confidence: 41%

CT-Angiographic Aspects of Pulmonary Embolism on SARS COV-2

Tiemtoré-Kambou

Ouédraogo

Dao

et al. 2023

Journal of the Belgian Society of Radiology

View full text Add to dashboard Cite

Objectives To study pulmonary embolism during COVID-19 pneumonia. Patients and Methods This was a one-year retrospective and descriptive study of all patients from three imaging sites with SARS-CoV2 infection. Results Two hundred and thirty-nine patients were included. The prevalence of pulmonary embolism was 18.4%. The average age was 55 years old. The sex ratio was 1.65. Dyspnea (58.6%), cough (56.1%), and chest pain (40.2%) were the most common reasons for consultation. In 151 patients (63.2%), chest computed tomography (CT) angiography was performed without checking level of D-dimer. The level of D-dimers was elevated in 47.8%. Grade 5 of CO-RADS accounted for 62.3%. In 70.5% of cases, the pulmonary embolism was bilateral with subsegmental involvement in 47.7%. Condensation in ‘ground glass’ with ‘crazy paving’ were the predominant typical parenchymal lesions with a frequency of 93.7% and 59.4%. In univariate analysis, D-dimers were significantly associated with the occurrence of pulmonary embolism (p < 0.001). Male sex was associated with a non-significantly higher Risk of having a pulmonary embolism (1.18 95% CI: 0.61–2.31, p = 0.622). The critical level increased the risk of pulmonary embolism in a non-significant way. Only the high level of D-dimers was and this, in a significant way. Conclusion Pulmonary embolism was increased in the context of SARS-CoV2. The chest CT-angiography associated with the dosage of D-dimers constitutes a good diagnostic arsenal.

show abstract

Section: Discussionmentioning

confidence: 41%

CT-Angiographic Aspects of Pulmonary Embolism on SARS COV-2

Tiemtoré-Kambou

Ouédraogo

Dao

et al. 2023

Journal of the Belgian Society of Radiology

View full text Add to dashboard Cite

show abstract

“…Nine patients had the distal pulmonary vascular disease (segmental and subsegmental), and 4 of them also had pulmonary infarction. This finding is not frequently reported despite the distal predominance of PE in COVID-19 16 .…”

Section: Discussionmentioning

confidence: 58%

Pulmonary Embolism (PE) Prevalence in Mexican-Mestizo Patients With Severe SARS-COV-2 (COVID-19) Pneumonia At A Tertiary-Level Hospital: A Review

Cueto-Robledo

Navarro-Vergara

Roldan-Valadez

et al. 2023

Current Problems in Cardiology

View full text Add to dashboard Cite

“…Most of these studies investigating the frequency of PTE in active COVID-19 disease are retrospective and include heterogeneous patient groups. In different centers, varying degrees of PTE incidence and prevalence have been reported in the presence of COVID-19 infection of different severity [6][7][8][9][10][11]. On the other hand, in our clinical practice, we observe that some patients who present with PTE have a previous COVID-19 infection despite the absence of other risk factors.…”

Section: Introductionmentioning

confidence: 59%

Evaluation of the Frequency of Previous Coronavirus Disease-19 as a Predisposing Factor in Pulmonary Thromboembolism and its Effect on Embolism Severity: A Multicenter, Observational, Cross-Sectional Study

Koçak,

Tutar,

Çil

et al. 2024

Preprint

View full text Add to dashboard Cite

Background Knowledge of predisposing factors in developing pulmonary thromboembolism (PTE) is important in the diagnosis and treatment approach. The association between past coronavirus disease-19 (COVID-19) infection and PTE is a potential research topic. In this study we aimed to determine the prevalence of previous COVID-19 in addition to all predisposing factors for PTE development and to determine whether there is a difference in embolism severity in these cases. Methods Study design: Multicenter, observational, cross-sectional.Patients diagnosed with PTE between March 11, 2022, and March 11, 2023, were prospectively included in the study. Group 1: PTE cases with previous COVID-19, Group 2: PTE cases without previous COVID-19.To compare the categorical variables between groups the chi-square test was used.For continuous variables, parametric and non-parametric tests were used.Multivariate binary logistic regression analysis was performed to determine the independent variables related to PTE severity that affected the presence of previous COVID-19. Results Forty-four researchers from 33 centers participated in our study.A total of 1185 patients were included (Group 1; n = 360, Group 2; n = 825). The median post-COVID duration was 120.0 (min-max: 30–980) days. Computed tomography pulmonary angiography (CTPA) right ventricle/left ventricle (RV/LV) ratio > 1 was significantly higher in Group 2 compared to Group 1 (27.9% vs 19.7%, p = 0.003).The proportion of patients receiving systemic thrombolytic drugs (11.3% vs. 7.5%, p = 0.048), and the rate of patients who started treatment in the intensive care unit was higher in Group 2 (23.4% vs. 14.7%, p = 0.001).In multivariate logistic regression analysis, the absence of any identifiable risk factor for PTE was found to be a 0.46-fold protective factor in the presence of previous COVID-19 (95% CI: 0.274–0.760, p = 0.003) and an RV/LV ratio > 1 on CTPA was found to be a 0.60-fold protective factor (95% CI: 0.365–0.998, p = 0.049). Conclusions The prevalence of previous COVID-19 infection in PTE cases was 30.4%, and 26% of idiopathic cases had previous COVID-19 infection.Although the parameters related to embolism severity were higher in the non-COVID-19 group, in multivariate analyses, only idiopathic status was associated with a 2.2-fold increased risk in non-COVID-19 patients compared to those who had, and an RV/LV ratio > 1 on CTPA was associated with a 1.7-fold increased risk.

show abstract

Pulmonary embolisms in patients with COVID-19: A prevalence study in a tertiary hospital

Cited by 12 publications

References 30 publications

CT-Angiographic Aspects of Pulmonary Embolism on SARS COV-2

CT-Angiographic Aspects of Pulmonary Embolism on SARS COV-2

Pulmonary Embolism (PE) Prevalence in Mexican-Mestizo Patients With Severe SARS-COV-2 (COVID-19) Pneumonia At A Tertiary-Level Hospital: A Review

Evaluation of the Frequency of Previous Coronavirus Disease-19 as a Predisposing Factor in Pulmonary Thromboembolism and its Effect on Embolism Severity: A Multicenter, Observational, Cross-Sectional Study

Contact Info

Product

Resources

About